[1] Seong SY,Matzinger P.Hydrophobicity:an ancient damage-associated molecular pattern that initiates innate immune responses.Nat Rev Immunol,2004,4:469-478.
[2] Handa P,Vemulakonda A,Kowdley KV,et al.Mitochondrial DNA from hepatocytes as a ligand for TLR9:Drivers of nonalcoholic steatohepatitis? World J Gastroenterol,2016,22:6965-6971.
[3] Ge X,Antoine DJ,Lu Y,et al.High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).J Biol Chem,2014,289:22672-22691.
[4] Nieto N,Friedman SL,Cederbaum AI.Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species.Hepatology,2002,35:62-73.
[5] Su L,Li N,Tang H,et al.Kupffer cell-derived TNF-alpha promotes hepatocytes to produce CXCL1 and mobilize neutrophils in response to necrotic cells.Cell Death Dis,2018,9:323.
[6] Buzzetti E,Pinzani M,Tsochatzis EA.The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).Metabolism,2016,65:1038-1048.
[7] Finkel T,Holbrook NJ.Oxidants,oxidative stress and the biology of ageing.Nature,2000,408:239-247.
[8] Kim SY,Jeong JM,Kim SJ,et al.Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex.Nat Commun,2017,8:2247.
[9] Sunny NE,Bril F,Cusi K.Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease:Novel Mechanisms and Treatment Strategies.Trends Endocrinol Metab,2017,28:250-260.
[10] Seitz HK,Bataller R,Cortez-Pinto H,et al.Alcoholic liver disease.Nat Rev Dis Primers,2018,4:16.
[11] Ma C,Kesarwala AH,Eggert T,et al.NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.Nature,2016,531:253-257.
[12] Klaebel JH,Skjodt M,Skat-Rordam J,et al.Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model.Nutrients,2019,11:2834.
[13] Walsh ME,Shi Y,Van Remmen H.The effects of dietary restriction on oxidative stress in rodents.Free Radic Biol Med,2014,66:88-99.
[14] Takeuchi O,Akira S.Pattern recognition receptors and inflammation.Cell,2010,140:805-820.
[15] Mridha AR,Wree A,Robertson AAB,et al.NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.J Hepatol,2017,66:1037-1046.
[16] Garcia-Martinez I,Santoro N,Chen Y,et al.Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9.J Clin Invest,2016,126:859-864.
[17] Sheedy FJ,Grebe A,Rayner KJ,et al.CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.Nat Immunol,2013,14:812-820.
[18] Zhao L,Zhang C,Luo X,et al.CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.J Hepatol,2018,69:705-717.
[19] Fu MX,Wells-Knecht KJ,Blackledge JA,et al.Glycation,glycoxidation,and cross-linking of collagen by glucose.Kinetics,mechanisms,and inhibition of late stages of the Maillard reaction.Diabetes,1994,43:676-683.
[20] Mederacke I,Hsu CC,Troeger JS,et al.Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.Nat Commun,2013,4:2823.
[21] Arriazu E,Ge X,Leung TM,et al.Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.Gut,2017,66:1123-1137.
[22] Rizk FH,Sarhan NI,Soliman NA,et al.Heat shock protein 47 as indispensible participant in liver fibrosis:Possible protective effect of lactoferrin.IUBMB Life 2018;70:795-805.
[23] Zhang L,Han J,Wu H,et al.The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma:a meta-analysis and literature review.PLoS One,2014,9:e110626.
[24] Donato R.RAGE:a single receptor for several ligands and different cellular responses:the case of certain S100 proteins.Curr Mol Med,2007,7:711-724.
[25] Chen M,Liu Y,Varley P,et al.High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.Cancer Res,2015,75:1645-1656.
[26] Cao L,Fan X,Jing W,et al.Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-kappaB-HIF-1alpha pathway.Oncotarget,2015,6:6627-6640.
[27] Guo Q,Wang J,Cao Z,et al.Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma.Int J Oncol,2018,53:592-602. |
